 | | PRD_002420 | | Name: | G2S2-oxazoline | | Formula: | C76 H124 N5 O56 | | Definition date: | 2024-07-03 | | Last modified: | 2024-07-03 |
|
 | | PRD_002404 | | Name: | Dynobactin A | | Formula: | C60 H78 N18 O16 | | Description: | 10mer peptide with distinct cyclophane rings. | | Definition date: | 2022-09-28 | | Last modified: | 2024-03-26 |
|
 | | PRD_002473 | | Name: | Agrocinopine A (beta-L-arabinopyranose form) | | Formula: | C17 H31 O18 P | | Description: | phosphodiester of sucrose and L-arabinose | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002485 | | Name: | [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | | Formula: | C21 H34 N6 O16 P2 | | Description: | unusual glycan purine conjugate (containing GLC and ADE) | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002506 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-4-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002507 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002508 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; beta-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002547 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002548 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; beta-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002517 | | Formula: | C66 H84 N10 O17 S | | Definition date: | 2023-12-06 | | Last modified: | 2023-12-06 |
|
 | | PRD_002466 | | Name: | Cyclohexyl-Griselimycin | | Formula: | C63 H106 N10 O12 | | Definition date: | 2023-11-29 | | Last modified: | 2023-11-29 |
|
 | | PRD_002489 | | Name: | lipid II mimetic, LPATA: Thr-in conformation | | Formula: | C53 H85 N14 O16 | | Definition date: | 2022-09-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000197 | | Name: | ALPHA LICHENICIDIN PREPEPTIDE | | Formula: | C142 H226 N36 O41 S5 | | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000212 | | Name: | Microcystin LR | | Formula: | C49 H75 N10 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000213 | | Name: | motuporin | | Formula: | C40 H57 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000292 | | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | | Formula: | C29 H50 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001125 | | Name: | Peptide ligand | | Formula: | C51 H75 N9 O14 | | Definition date: | 2013-12-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_002103 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C30 H51 N5 O8 S | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002107 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H47 N5 O8 S2 | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002111 | | Name: | 3,5-difluoro-Nalpha-[(2E,5S)-5-methylhept-2-enoyl]-N-[(2S,6aS,12S,13R,15aS,21S,23aS)-2,13,21-trimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-L-phenylalaninamide | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2023-11-03 |
|
 | | PRD_002126 | | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | | Formula: | C38 H54 N7 O10 P | | Definition date: | 2014-12-03 | | Last modified: | 2023-11-03 |
|
 | | PRD_000781 | | Name: | Thr-Asp-F-amidine | | Formula: | C17 H29 F N6 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002365 | | Name: | phazolicin | | Formula: | C74 H104 N29 O27 S3 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000156 | | Name: | Cephaibol A | | Formula: | C82 H127 N17 O20 | | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000157 | | Name: | Cephaibol B | | Formula: | C83 H129 N17 O20 | | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
